| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.18▲ | 2.11▲ | 2.12▲ | 2.44▼ | 2.32▼ |
| MA10 | 2.13▲ | 2.11▲ | 2.14▲ | 2.62▼ | 2.10▲ |
| MA20 | 2.12▲ | 2.15▲ | 2.32▼ | 2.51▼ | 1.92▲ |
| MA50 | 2.14▲ | 2.48▼ | 2.54▼ | 2.06▲ | 2.08▲ |
| MA100 | 2.38▼ | 2.60▼ | 2.61▼ | 1.94▲ | 2.67▼ |
| MA200 | 2.51▼ | 2.55▼ | 2.37▼ | 1.99▲ | 5.80▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | 0.027▲ | 0.002▲ | -0.094▼ | 0.090▲ |
| RSI | 64.375▲ | 49.156▼ | 43.665▼ | 46.575▼ | 52.647▲ |
| STOCH | 96.573▲ | 47.661 | 34.465 | 23.156 | 49.703 |
| WILL %R | -6.000▲ | -6.000▲ | -6.000▲ | -86.798▼ | -61.554 |
| CCI | 154.519▲ | 168.065▲ | 87.838 | -99.014 | 26.845 |
|
Monday, May 18, 2026 05:10 AM
Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved ...
|
|
Thursday, May 14, 2026 10:15 PM
Dare Bioscience Inc (DARE) announces key product launches and funding strategies amid capital constraints and regulatory hurdles.
|
|
Thursday, May 14, 2026 02:05 PM
Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/05/26 | 2.075 | 2.25 | 2.00 | 2.235 | 264,597 |
| 18/05/26 | 2.10 | 2.2299 | 2.0916 | 2.11 | 479,221 |
| 15/05/26 | 2.20 | 2.3299 | 2.05 | 2.17 | 1,216,488 |
| 14/05/26 | 2.85 | 3.10 | 2.68 | 2.86 | 1,060,327 |
| 13/05/26 | 2.63 | 2.84 | 2.52 | 2.84 | 503,385 |
| 12/05/26 | 2.42 | 2.7289 | 2.34 | 2.63 | 606,144 |
| 11/05/26 | 2.71 | 2.8488 | 2.43 | 2.52 | 746,324 |
| 08/05/26 | 2.94 | 2.94 | 2.65 | 2.75 | 554,011 |
| 07/05/26 | 3.05 | 3.0699 | 2.72 | 2.91 | 734,174 |
| 06/05/26 | 3.36 | 3.40 | 2.69 | 3.16 | 1,573,935 |
|
|
||||
|
|
||||
|
|